Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.72 EUR
Change Today -0.023 / -3.11%
Volume 541.9K
ECR On Other Exchanges
As of 11:38 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

ercros sa (ECR) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/22/15 - €0.77
52 Week Low
12/31/14 - €0.38
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ERCROS SA (ECR)

Related News

No related news articles were found.

ercros sa (ECR) Related Businessweek News

No Related Businessweek News Found

ercros sa (ECR) Details

Ercros, S.A. manufactures and markets basic and intermediate chemicals, plastics, and pharmaceuticals primarily in Spain. Its Basic Chemicals division offers ammonia, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, hydrochloric acid, hydrogen peroxide, potassium carbonate, and phosphates, as well as sodium chlorate, chloride, chlorite, and hypochlorite. This division’s products are used in chemical industry, derivatives manufacturing, swimming pools, compound fodder, paper pulp bleaching, and water treatment applications. Its Plastics division provides dichloroethane, vinyl chloride monomer, vinyl polychloride (VCM), and polyvinyl chloride (PVC) compounds for use in VCM and PVC manufacturing and construction applications. The company’s Intermediate Chemicals division offers formaldehyde, glues and resins, moulding compounds, paraformaldehyde, pentaerythritol, and sodium formate, which are used in derivatives manufacturing, wood industry, electrotechnics, resins, paints, and tanning industry applications. Its Pharmaceuticals division focuses on the production of raw materials and intermediary pharmaceutical products of antibiotics, hypercholesterolemia, anti-ulcer, and anti-fungal products. This division offers erythromycins, fusidic acid, and fosfomycins for use in antibiotic and skin infections. The company also exports its product to approximately 128 countries. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Founded in 1817

ercros sa (ECR) Top Compensated Officers

Chairman, Chief Executive Officer and Member ...
Total Annual Compensation: €465.1K
Compensation as of Fiscal Year 2014.

ercros sa (ECR) Key Developments

Ercros, S.A. expected to report First-Half, 2015 results on July 30, 2015. This event was calculated by Capital IQ (Created on July 24, 2015).

Ercros, S.A. expected to report First-Half, 2015 results on July 30, 2015. This event was calculated by Capital IQ (Created on July 24, 2015).

Ercros, S.A., Annual General Meeting, Jun 29, 2015

Ercros, S.A., Annual General Meeting, Jun 29, 2015., at 12:00 Central European Standard Time. Location: Mutual Gene Insurance Entenza street, 325-335.

Ercros Reports Consolidated Earnings Results for the First Quarter of 2015

Ercros reported consolidated earnings results for the first quarter of 2015. For the quarter, the company reported profit of EUR 0.40 million compared to a loss of EUR 2.78 million incurred in the same period of 2014, a difference of EUR 3.18 million. Turnover was EUR 152.41 million against EUR 149.69 million a year ago. Income was EUR 150.35 million against EUR 147.03 million a year ago. EBITDA was EUR 5.26 million against EUR 4.42 million a year ago. EBIT was EUR 0.28 million against EUR 0.23 million a year ago. Profit before tax was EUR 0.39 million against loss before tax of EUR 2.78 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECR:SM €0.72 EUR -0.023

ECR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ECR.
View Industry Companies

Industry Analysis


Industry Average

Valuation ECR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.5x
Price/Cash Flow 5.1x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ERCROS SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at